ConductScience.org, home

Paper40435995

TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection.

Luu AM and 7 others. J Innate Immun, 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection. Papers, record 40435995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40435995

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection.
PubMed
Journal
J Innate Immun
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-06-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luu AMAbby M
2Hatton AAAlexis A
3Gattiker JJasper
4Shepardson KMKelly M
5Hall MNMonica N
6Benson EEvelyn
7Bimczok DDiane
8Rynda-Apple AAgnieszka

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Toll-Like Receptor 2Major topic
Staphylococcus aureusMajor topic
Staphylococcal InfectionsMajor topic
Toll-Like Receptor 4Major topic
MacrophagesMajor topic
Tumor Necrosis Factor-alphaMajor topic
Animals
Mice
Mice, Knockout
Mice, Inbred C57BL
Cells, Cultured
Macrophage Activation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 AI171903NIAID NIH HHSUnited StatesR21AI171903PubMed and NIHNIH RePORTER
TL1 TR002318NCATS NIH HHSUnited StatesTL1TR002318PubMed and NIHNIH RePORTER

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126582142Dual transcriptome sequencing reveals resistance of TLR4 ligand-activated bone marrow-derived macrophages to inflammation mediated by the BET inhibitor JQ1.Sci Rep2015https://conductscience.org/library/papers/26582142PubMed
231363069Noncompetitive inhibitors of TNFR1 probe conformational activation states.Sci Signal2019https://conductscience.org/library/papers/31363069PubMed
311992285The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.J Infect Dis2002https://conductscience.org/library/papers/11992285PubMed
419448156Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung.Am J Respir Cell Mol Biol2010https://conductscience.org/library/papers/19448156PubMed
529378181The E3 ubiquitin ligases HOIP and cIAP1 are recruited to the TNFR2 signaling complex and mediate TNFR2-induced canonical NF-κB signaling.Biochem Pharmacol2018https://conductscience.org/library/papers/29378181PubMed
623704210Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells.Cancer Res2013https://conductscience.org/library/papers/23704210PubMed
733270628Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2.PLoS Biol2020https://conductscience.org/library/papers/33270628PubMed
818161744Macrophage activation by endogenous danger signals.J Pathol2008https://conductscience.org/library/papers/18161744PubMed
925624856Tumor necrosis factor inhibitors - state of knowledge.Arch Med Sci2014https://conductscience.org/library/papers/25624856PubMed
1023436141Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.Mol Neurobiol2013https://conductscience.org/library/papers/23436141PubMed
1133986920Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis.Sci Signal2021https://conductscience.org/library/papers/33986920PubMed
1228323513Transmembrane TNF-dependent uptake of anti-TNF antibodies.MAbs2017https://conductscience.org/library/papers/28323513PubMed
1333336901Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.J Cell Mol Med2021https://conductscience.org/library/papers/33336901PubMed
1415890966Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.J Virol2005https://conductscience.org/library/papers/15890966PubMed
1530794556Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections.PLoS One2019https://conductscience.org/library/papers/30794556PubMed
167540941Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.Immunity1995https://conductscience.org/library/papers/7540941PubMed
1733824270Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist.Cell Death Dis2021https://conductscience.org/library/papers/33824270PubMed
1824163075Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.Am J Physiol Heart Circ Physiol2014https://conductscience.org/library/papers/24163075PubMed
1911117919Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.Lancet2000https://conductscience.org/library/papers/11117919PubMed
2028431162Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.Rheumatology (Oxford)2018https://conductscience.org/library/papers/28431162PubMed

See all 62 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41689830Editors' Choice 2025 <italic>Journal of Innate Immunity</italic>: From Receptor Proximal Training to Metabolic and Fibrotic Control.J Innate Immun2026https://conductscience.org/library/papers/41689830

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40435995

GET https://conductscience.org/api/papers/v1/40435995/references?page=2